Medica2015_Mittwoch

WEDNESDAY @ MEDICA 3 EH @ MEDICA No 3 2015 Editor-in-Chief: Brenda Marsh Art Director: Olaf Skrober Managing Editor: Sylvia Schulz Editorial team: Sascha Keutel, Marcel Rasch Senior Writer: John Brosky Executive Director: Daniela Zimmermann Founded by Heinz-Jürgen Witzke Correspondents Austria: Michael Kraßnitzer, Christian Pruszinsky. China: Nat Whitney France: Annick Chapoy, Jane MacDougall.Germany: Anja Behringer, Annette Bus, Walter Depner, Bettina Döbereiner, Matthias Simon, Axel Viola, Cornelia Wels-Maug, Holger Zorn. Great Britain: Brenda Marsh, Mark Nicholls. Malta: Moira Mizzi. Poland: Pjotr Szoblik. Russia: Olga Ostrovskaya, Alla Astachova. Spain: Mélisande Rouger, Eduardo de la Sota. Switzerland: Dr. André Weissen. USA: Cynthia E. Keen, i.t. Communications, Nat Whitney. Subscriptions Janka Hoppe, European Hospital, Theodor-Althoff-Str. 45, 45133 Essen, Germany Subscription rate 6 issues: 42 Euro, Single copy: 7 Euro. Send order and cheque to: European Hospital Subscription Dept Printed by: WVD, Mörfelden-Walldorf, Germany Publication frequency: bi-monthly European Hospital ISSN 0942-9085 Representatives China & Hongkong: Gavin Hua, Sun China Media Co, Ltd. Phone: +86-0755-81 324 036 E-Mail: gh@european-hospital.com Germany, Austria, Switzerland: Ralf Mateblowski Phone: +49 6735 912 993 E-Mail: rm@european-hospital.com France, Italy, Spain: Eric Jund Phone: +33 493 58 77 43 E-Mail: ej@european-hospital.com GB, Scandinavia, BeNeLux: Simon Kramer Phone/Fax: +31 180 6200 20 E-Mail: sk@european-hospital.com Israel: Hannah Wizer, International Media Dep. of El-Ron Adv. & PR Co., Ltd. Phone: +972-3-6 955 367 E-Mail: hw@european-hospital.com South Korea: CH Park, MCI Phone: +82 2 730 1234 E-Mail: chp@european-hospital.com USA & Canada: Hanna Politis, Media International Tel: +1 301 869 66 10 E-Mail: hp@european-hospital.com adenoma detection rate questions are currently being investi- gated in clinical trials. Applications beyond gastroenterology Problems in pneumology have also become easy to investigate using EXERA III and narrow band imag- ing. In addition to NBI, a further procedure for aiding diagnosis will be of interest to the pneumologist: autofluorescence. In this case, light is not absorbed, but is taken up by tissue components, such as collagen, where it is transformed into light with a different wavelength. If this light information is attenuated in specific areas, then this may indicate the presence of pathological pro- cesses. However, the EXERA III series does not have the autofluorescence (AFI) mode. For technical reasons, this is only available in the LUCERA series that is mainly used in Asia. Feuring: ‘We do, however, cur- rently offer the pneumologist the option of combining the two video processors that are required, using a universal light source, enabling NBI and AFI to be used with the com- patible endoscopes. I would like to see these two series, the European and the Asian series, being merged further.’ Computer-assisted endos- copy and 3-D imaging As for future perspectives, this prod- uct manager is optimistic that devel- opments such as computer-assisted diagnostics will also will also be able to support the physician in the identification of potentially suspect tissues. This problem is going to be the subject of joint research with the University hospital of Jena. In contrast to laparoscopy, 3-D imaging with a flexible endoscope is currently also a long way off in flex- ible endoscopy, even if it is of interest to the user. ‘3-D endoscopy could provide potential advantages in the remov- al of polyps,’ Feuring suggests. ‘Technological development will con- tinue, that is certain. But no matter how much innovative technology is involved, a trained eye and a learn- ing curve will also be essential for successful applications in the future. ‘Perhaps NBI will even mean that tissue biopsies will not be required in specific cases - that is the vision of the future. An analysis for the USA (Kessler W R et al. A quantita- tive assessment of the risks and cost savings of forgoing histological examination of diminutive polyps… Endoscopy 2011; 43: 683–691) revealed that one billion dollars could be saved there alone if hyperplastic polyps of up to 5 millimetres no longer needed to be removed and sent to the pathologist. In many cases, endoscopic results are unambiguous and the patholo- gist only needs to verify them.’ Mirko Feuring, GI Product Manager at Flexible Endoscopy, Olympus Deutschland GmbH EH @ MEDICA No 32015 Phone: +86-0755-81324036 Phone: +496735912993 Phone: +33493587743 Phone/Fax: +31180620020 Phone: +972-3-6955367 Phone: +8227301234 Tel: +13018696610

Pages Overview